Abstract:Purpose: In this study, we designed a new linear 6-Hydrazinonicotinamide (HYNIC)-conjugated peptide (HYNIC-KRWrNM) (M-6) and labeled with technetium-99m for gamma imaging of glioblastoma as a αvβ3-positive tumor. We evaluated tumor targeting ability of this radio-peptide and compared with previous 99mTc-labeled HYNIC-conjugated RGD analogue peptides. Procedures: One new linear peptide (HYNIC-KRWrNM) (M-6) was designed and labeled with technetium-99m in the presence of 2-[[1,3-dihydroxy-2-(hydroxymethyl) propan-2-yl] amino] acetic acid (Tricine)/Ethylenediamine-N,N'-diacetic acid (EDDA) as co-ligand system. Then, this 99mTc-labeled peptide ([99mTc]Tc-M-7) was evaluated for in vitro stability in saline and serum, specific binding assay, internalization, and binding affinity (Kd). In addition, we performed biodistribution study and planar imaging on nude mice bearing U87-MG xenograft as a αvβ3-positive tumor. Results: The radiochemical yield of [99mTc]Tc-M-7 was obtained ˃95%. This 99mTc-labeled peptide remained stable and intact in saline solution after 24 h incubation. In addition, metabolic stability of this 99mTc-labeled peptide was obtained ˃60% after 4 h incubation in serum. The Kd value for [99mTc]Tc-M-7 was obtained 5.2 ± 1.0 nM. Based on biodistribution results in nude mice bearing U87-MG xenograft, tumor/muscle activity ratio was 6.22 and decreased to 1.89 in blocking group at the same time point (4 h p.i.). The blocking experiment results also indicated that tumor uptake and kidney uptake were αvβ3-mediated. In comparison with previous HYNIC-conjugated RGD analogue peptides, kidneys had the highest uptake of this 99mTc-labeled peptide (52.29 ± 11.48 at 1.5 h p.i. and 27.04 ± 0.66%ID/g at 4 h p.i.). Finally, similar to previous 99mTc-labeled HYNIC-conjugated RGD analogue peptides, [99mTc]Tc-M-7 showed acceptable tumor uptake after 4 h post-injection (based on ROI technique, target-to-background activity ratio = 3.80). Conclusions: This small linear 99mTc-labeled peptide, with high affinity to αvβ3 integrin, desirable water solubility, and cost efficient, demonstrates a potent tumor targeting ability as well as previous HYNIC-conjugated RGD analogue peptides. Hence, [99mTc]Tc-M-7 can be of service to as a new candidate for early detection of αvβ3-positive tumors.

Biodistribution and Pharmacokinetics of 99tcm Labeled Carbohydrated Peptides in Mice Bearing Tumors

Tumor Locating Property of ~(99)Tc~m-Mavgg-glucose

Biodistribution and SPECT Imaging Study Of99mtc Labeling NGR Peptide in Nude Mice Bearing Human HepG2 Hepatoma

99Tcmn-Dgdtc,a New Glucose Metabolic Agent,the Pharmacokinetics and Imaging Results

Biodistribution and Imaging of 99m Tc-MAVGG-adenine in Tumor Bearing Mice

The preparation and biological evaluation of 99mTc-MAG3-glucose

Synthesis and Evaluation of 99Mtc–2-[(3-carboxy-1-oxopropyl)amino]-2-deoxy-d-glucose As a Potential Tumor Imaging Agent

Comparative Biodistribution of Potential Anti-Glioblastoma Conjugates [111In]dtpa-Hegf and [111In]bz-Dtpa-hegf in Normal Mice

Preparation and Bioevaluation of a Novel 99Mtc-Labeled Glucose Derivative Containing Cyclohexane As a Promising Tumor Imaging Agent

The Biodistribution of Technetium-99m Labeled Glucose ~(99)Tc~m-Ec-dg in S180 Sarcoma Tumor-bearing Mice

Studies on distribution and imaging of 131I-labelled RGD peptide in mice bearing tumors

Noninvasive Scintigraphic Detection of Tumor with 99Mtc-Dtpa-deoxyglucose: an Experimental Study.

Synthesis and Biodistribution of 99Tcm-MAG2-Ade as A Tumor Imaging Agent

Novel 99Mtc-Labeled Glucose Derivative for Single Photon Emission Computed Tomography: A Promising Tumor Imaging Agent

Synthesis and biological evaluation of a &lt;sup&gt;99m&lt;/sup&gt;Tc-labeled glucose derivative for tumor imaging

Synthesis and Biodistribution of 99Mtc-Peptides Conjugated Adenine As Tumor Imaging Agents

The Preparation and Execution of Exploratory Human Studies on Novel 99Mtc-Labeled Glucosamine Derivatives Containing Different Phenyl Isonitriles As Promising Tumor Imaging Agents.

Evaluation of 99Mtc-Cn5dg As a Broad-Spectrum SPECT Probe for Tumor Imaging

[99mTc]-labeling and evaluation of a new linear peptide for imaging of glioblastoma as a αvβ3-positive tumor

Improving the Tumor Uptake of Peptides by Conjugation of Uridin

Radiolabeling of Filamentous Phage Peptide Library with ~(99m)tc and Its Biodistribution in Normal Mice